Mesothelioma R&D eyes UK funding breakthrough
This article was originally published in Clinica
Executive Summary
The UK government says it is close to announcing a review of its policy on compensation for patients with pleural plaques associated with exposure to asbestos in the workplace, in a move that holds potential major significance to medtech R&D in this area.